FARMACIA Y TECNOLOGÍA FARMACÉUTICA
DEPARTAMENTO
![Foto de FARMACIA Y TECNOLOGÍA FARMACÉUTICA](/img/noimage.png)
![Foto de Hospital de Poniente](/img/noimage_org.png)
Hospital de Poniente
El Ejido, EspañaPublicacións en colaboración con investigadores/as de Hospital de Poniente (5)
2021
-
Impact of a risk-sharing agreement in rheumatoid arthritis in Spain
Health Policy, Vol. 125, Núm. 3, pp. 335-340
-
Influence of the fcgr2a rs1801274 and fcgr3a rs396991 polymorphisms on response to abatacept in patients with rheumatoid arthritis
Journal of Personalized Medicine, Vol. 11, Núm. 6
2020
-
Efficacy and safety of a novel submucosal injection solution for resection of gastrointestinal lesions
Journal of Clinical Medicine, Vol. 9, Núm. 4
-
Impact of single-nucleotide polymorphisms of CTLA-4, CD80 and CD86 on the effectiveness of abatacept in patients with rheumatoid arthritis
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-17
2013
-
The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-κB/MAPK activation
Food Chemistry, Vol. 136, Núm. 3-4, pp. 1288-1295